Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

21. The impacts of public mammography screening on the relationship between socioeconomic status and cancer stage

The impacts of public mammography screening on the relationship between socioeconomic status and cancer stage 29349166 2018 11 13 2352-8273 2 2016 Dec SSM - population health SSM Popul Health The impacts of public mammography screening on the relationship between socioeconomic status and cancer stage. 502-511 10.1016/j.ssmph.2016.07.002 This study aimed to investigate the relationship between socioeconomic inequality and mortality following the introduction of a public mammography screening (...) the introduction of a public mammography program. Klitkou Søren T ST Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway. eng Journal Article 2016 08 03 England SSM Popul Health 101678841 2352-8273 Br J Cancer. 2016 Mar 1;114(5):590-6 26835975 Soc Sci Med. 2003 Dec;57(12):2265-79 14572836 Eur J Cancer Prev. 2005 Feb;14(1):7-12 15677890 Epidemiology. 2011 Jul;22(4):575-81 21552129 J Natl Cancer Inst. 2008 Aug 6;100(15):1082-91 18664650 Popul

SSM - population health2016 Full Text: Link to full Text with Trip Pro

22. Ultrasound as an Adjunct to Mammography for Breast Cancer Screening

Ultrasound as an Adjunct to Mammography for Breast Cancer Screening Health Quality Ontario The provincial advisor on the quality of health care in Ontario Let’s make our health system healthier Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: OHTAC Recommendation ONTARIO HEALTH TECHNOLOGY ADVISORY COMMITTEE RECOMMENDATIONS ? The Ontario Health Technology Advisory Committee recommends publicly funding screening breast ultrasound as an adjunct to screening mammography for high (...) -risk women in whom magnetic resonance imaging (MRI) is contraindicated. ? The Ontario Health Technology Advisory Committee recommends against publicly funding screening breast ultrasound as an adjunct to screening mammography in women at average risk for breast cancer. RATIONALE FOR THE RECOMMENDATION DECISION Given the absence of evidence demonstrating benefit, 1 there was consensus among members of the Ontario Health Technology Advisory Committee (OHTAC) that adjunct screening breast ultrasound

Health Quality Ontario2016

23. Cost-Effectiveness of Three Rounds of Mammography Breast Cancer Screening in Iranian Women

Cost-Effectiveness of Three Rounds of Mammography Breast Cancer Screening in Iranian Women 27366315 2016 07 01 2018 11 13 2008-2398 9 1 2016 Feb Iranian journal of cancer prevention Iran J Cancer Prev Cost-Effectiveness of Three Rounds of Mammography Breast Cancer Screening in Iranian Women. e5443 10.17795/ijcp-5443 Breast cancer is the most common cancer in Iranian women as is worldwide. Mammography screening has been introduced as a beneficial method for reducing mortality and morbidity (...) of this disease. We developed an analytical model to assess the cost effectiveness of an organized mammography screening program in Iran for early detection of the breast cancer. This study is an economic evaluation of mammography screening program among Iranian woman aged 40 - 70 years. A decision tree and Markov model were applied to estimate total quality adjusted life years (QALY) and lifetime costs. The results revealed that the incremental cost effectiveness ratio (ICER) of mammography screening

Iranian journal of cancer prevention2016 Full Text: Link to full Text with Trip Pro

24. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study.

Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study. BACKGROUND: Estimates of risk for radiation-induced breast cancer from mammography screening have not considered variation in dose exposure or diagnostic work-up after abnormal screening results. OBJECTIVE: To estimate distributions of radiation-induced breast cancer incidence and mortality from digital mammography screening while considering exposure from screening and diagnostic (...) mammography and dose variation among women. DESIGN: 2 simulation-modeling approaches. SETTING: U.S. population. PATIENTS: Women aged 40 to 74 years. INTERVENTION: Annual or biennial digital mammography screening from age 40, 45, or 50 years until age 74 years. MEASUREMENTS: Lifetime breast cancer deaths averted (benefits) and radiation-induced breast cancer incidence and mortality (harms) per 100,000 women screened. RESULTS: Annual screening of 100,000 women aged 40 to 74 years was projected to induce 125

Annals of Internal Medicine2016 Full Text: Link to full Text with Trip Pro

25. Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data.

Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data. BACKGROUND: Women screened with digital mammography may receive false-positive and false-negative results and subsequent imaging and biopsies. How these outcomes vary by age, time since the last screening, and individual risk factors is unclear. OBJECTIVE: To determine factors associated with false-positive and false-negative digital mammography results (...) , additional imaging, and biopsies among a general population of women screened for breast cancer. DESIGN: Analysis of registry data. SETTING: Participating facilities at 5 U.S. Breast Cancer Surveillance Consortium breast imaging registries with linkages to pathology databases and tumor registries. PATIENTS: 405,191 women aged 40 to 89 years screened with digital mammography between 2003 and 2011. A total of 2963 were diagnosed with invasive cancer or ductal carcinoma in situ within 12 months of screening

Annals of Internal Medicine2016 Full Text: Link to full Text with Trip Pro

26. Recall Rates for Digital Mammography for Patients Undergoing Screening for Breast Cancer: Evidence-Based Guidelines

Recall Rates for Digital Mammography for Patients Undergoing Screening for Breast Cancer: Evidence-Based Guidelines Recall Rates for Digital Mammography for Patients Undergoing Screening for Breast Cancer: Evidence-Based Guidelines | CADTH.ca Find the information you need Recall Rates for Digital Mammography for Patients Undergoing Screening for Breast Cancer: Evidence-Based Guidelines Recall Rates for Digital Mammography for Patients Undergoing Screening for Breast Cancer: Evidence (...) -Based Guidelines Published on: September 30, 2015 Project Number: RB0917-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What are the evidence-based guidelines regarding appropriate recall for patients undergoing digital mammography for breast cancer screening? Key Message No relevant evidence-based guidelines were identified regarding appropriate recall for patients undergoing digital mammography for breast cancer screening. Tags false

Canadian Agency for Drugs and Technologies in Health - Rapid Review2015

27. Breast cancer screening and mammography: inform women

Breast cancer screening and mammography: inform women Prescrire IN ENGLISH - Spotlight ''Breast cancer screening and mammography: inform women '', 1 July 2015 {1} {1} {1} | | > > > Breast cancer screening and mammography: inform women Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Breast cancer screening and mammography: inform women Information (...) must be shared with women to help them decide whether or not to take part in breast cancer screening. In a series of articles published over the past year, Prescrire updated its analysis of the harm-benefit balance of breast cancer screening by mammography. In France, it is estimated that, overall, for every 1000 woman aged 50, around 72 women are diagnosed with breast cancer over a period of 20 years. In the 10 years following this diagnosis, around 13 of these women die from breast cancer, and 4

Prescrire2015

28. Tomosynthesis (3D Mammography) for Breast Cancer Screening

Tomosynthesis (3D Mammography) for Breast Cancer Screening 1 Issue 135 ? May 2015 Issues in Emerging Health Technologies Summary ? Digital breast tomosynthesis (DBT) is a novel imaging technology that captures three- dimensional (3D) images of the breast. ? DBT can be used for screening or diagnosis. ? Seven recent, large screening studies that each enrolled more than 10,000 women showed that DBT can reduce the need to recall women for further testing compared with current two- dimensional (2D (...) Traditional two-dimensional (2D) mammography captures two static images of the breast. One particular shortcoming of 2D technology is the overlapping of breast images that can decrease accuracy of interpretation. With digital breast tomosynthesis (DBT), an X-ray beam sweeps in an arc of 15 to 50 degrees (depending on the manufacturer) across the breast, and an electronic detector digitally captures between nine and 25 X-ray projection images. 1-6 These images are generally captured in two views

Canadian Agency for Drugs and Technologies in Health - Rapid Review2015

29. Tomosynthesis (3D Mammography) for Breast Cancer Screening

Tomosynthesis (3D Mammography) for Breast Cancer Screening Tomosynthesis (3D Mammography) for Breast Cancer Screening | CADTH.ca Find the information you need Tomosynthesis (3D Mammography) for Breast Cancer Screening Tomosynthesis (3D Mammography) for Breast Cancer Screening Published on: May 13, 2015 Project Number: EH0026 Product Line: Issue: 135 Result type: Report Summary Digital breast tomosynthesis (DBT) is a novel imaging technology that captures three-dimensional (3D) images (...) detection. Implementation issues include the significant cost to purchase the technology, training requirements for radiologists and technologists, increased radiologist interpretation time, and greater data storage requirements. The Technology Traditional two-dimensional (2D) mammography captures two static images of the breast. One particular shortcoming of 2D technology is the overlapping of breast images that can decrease accuracy of interpretation. With digital breast tomosynthesis (DBT), an X-ray

CADTH - Issues in Emerging Health Technologies2015

30. Concurrent versus Sequential Digital Mammography and MRI for Breast Cancer Screening in High-Risk Patients

Concurrent versus Sequential Digital Mammography and MRI for Breast Cancer Screening in High-Risk Patients Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed (...) Sequential Digital Mammography and MRI for Breast Cancer Screening in High-Risk Patients: Comparative Clinical Effectiveness, Cost- Effectiveness, and Guidelines DATE: 06 May 2015 RESEARCH QUESTIONS 1. What is the comparative clinical effectiveness of concurrent versus sequential digital mammography and magnetic resonance imaging (MRI) for breast cancer screening in high-risk patients? 2. What is the comparative cost-effectiveness of concurrent versus sequential digital mammography and MRI for breast

Canadian Agency for Drugs and Technologies in Health - Rapid Review2015

31. The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme - a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with

The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme - a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with TOMMY trial: A comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry (...) - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> {{metadata.Title}} {{metadata.Headline}} The study found that in cancer detection the specificity of digital breast tomosynthesis and two-dimensional (2D) mammography was better than 2D mammography alone but there was only a marginal improvement in sensitivity. Synthetic 2D mammography was found

NIHR HTA programme2015

32. Full-field digital mammography for breast cancer screening

Full-field digital mammography for breast cancer screening Full-field digital mammography for breast cancer screening Full-field digital mammography for breast cancer screening HAYES, Inc. Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc.. Full-field digital mammography for breast cancer screening. Lansdale: HAYES, Inc.. Directory Publication. 2015 (...) Final publication URL The report may be purchased from: Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasms; Early Detection of Cancer; Humans; Mammography Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32016000106 Date abstract

Health Technology Assessment (HTA) Database.2015

33. Management of Women With Dense Breasts Diagnosed by Mammography

Management of Women With Dense Breasts Diagnosed by Mammography Management of Women With Dense Breasts Diagnosed by Mammography - ACOG Menu ▼ Management of Women With Dense Breasts Diagnosed by Mammography Page Navigation ▼ A correction was published in January 2016 for this title. Click to view the correction. Number 625, March 2015 (Reaffirmed 2017) Committee on Gynecologic Practice This document reflects emerging clinical and scientific advances as of the date issued and is subject to change (...) . The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Management of Women With Dense Breasts Diagnosed by Mammography ABSTRACT: Women with dense breasts have a modestly increased risk of breast cancer and experience reduced sensitivity of mammography to detect breast cancer. However, evidence is lacking to advocate for additional testing until there are clinically validated data that indicate improved screening outcomes. Currently, screening

American College of Obstetricians and Gynecologists2015

34. Use of Digital Breast Tomosynthesis with Mammography for Breast Cancer Screening or Diagnosis

Use of Digital Breast Tomosynthesis with Mammography for Breast Cancer Screening or Diagnosis Use of digital breast tomosynthesis with mammography for breast cancer screening or diagnosis Use of digital breast tomosynthesis with mammography for breast cancer screening or diagnosis BlueCross BlueShield Association Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation (...) BlueCross BlueShield Association. Use of digital breast tomosynthesis with mammography for breast cancer screening or diagnosis. Chicago: BlueCross BlueShield Association (BCBS). TEC Assessment 28(6). 2014 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasmss; Imaging, Three-Dimensional; Mammography; Mass Screening Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence

Health Technology Assessment (HTA) Database.2014

35. Breast cancer screening using tomosynthesis in combination with digital mammography.

Breast cancer screening using tomosynthesis in combination with digital mammography. IMPORTANCE: Mammography plays a key role in early breast cancer detection. Single-institution studies have shown that adding tomosynthesis to mammography increases cancer detection and reduces false-positive results. OBJECTIVE: To determine if mammography combined with tomosynthesis is associated with better performance of breast screening programs in the United States. DESIGN, SETTING, AND PARTICIPANTS (...) : Retrospective analysis of screening performance metrics from 13 academic and nonacademic breast centers using mixed models adjusting for site as a random effect. EXPOSURES: Period 1: digital mammography screening examinations 1 year before tomosynthesis implementation (start dates ranged from March 2010 to October 2011 through the date of tomosynthesis implementation); period 2: digital mammography plus tomosynthesis examinations from initiation of tomosynthesis screening (March 2011 to October 2012

JAMA2014 Full Text: Link to full Text with Trip Pro

36. Modern mammography screening and breast cancer mortality: population study.

Modern mammography screening and breast cancer mortality: population study. OBJECTIVE: To evaluate the effectiveness of contemporary mammography screening using individual information about screening history and breast cancer mortality from public screening programmes. DESIGN: Prospective cohort study of Norwegian women who were followed between 1986 and 2009. Within that period (1995-2005), a national mammography screening programme was gradually implemented, with biennial invitations sent (...) for screening. We took competing causes of death into account by censoring women from further follow-up who died from other causes. Based on the observed mortality reduction combined with the all cause and breast cancer specific mortality in Norway in 2009, we used the CISNET (Cancer Intervention and Surveillance Modeling Network) Stanford simulation model to estimate how many women would need to be invited to biennial mammography screening in the age group 50-69 years to prevent one breast cancer death

BMJ2014 Full Text: Link to full Text with Trip Pro

37. Abolishing Mammography Screening Programs? A View from the Swiss Medical Board.

Abolishing Mammography Screening Programs? A View from the Swiss Medical Board. Abolishing mammography screening programs? A view from the Swiss Medical Board. - PubMed - NCBI Warning: The NCBI web site requires JavaScript to function. Search database Search term Search Result Filters Format Summary Summary (text) Abstract Abstract (text) MEDLINE XML PMID List Apply Choose Destination File Clipboard Collections E-mail Order My Bibliography Citation manager Format Create File 1 selected item (...) : 24738641 Format MeSH and Other Data E-mail Subject Additional text E-mail Add to Clipboard Add to Collections Order articles Add to My Bibliography Generate a file for use with external citation management software. Create File 2014 May 22;370(21):1965-7. doi: 10.1056/NEJMp1401875. Epub 2014 Apr 16. Abolishing mammography screening programs? A view from the Swiss Medical Board. 1 , . 1 From the Institute of Biomedical Ethics, University of Zurich, Zurich (N.B.-A.), and the Institute of Social

NEJM2014 Full Text: Link to full Text with Trip Pro

38. Screening mammography in older women: a review.

Screening mammography in older women: a review. IMPORTANCE: Guidelines recommend individualizing screening mammography decisions for women aged 75 years and older. However, little pragmatic guidance is available to help counsel patients. OBJECTIVE: To provide an evidence-based approach for individualizing decision-making about screening mammography in older women. EVIDENCE ACQUISITION: We searched PubMed for English-language studies in peer-reviewed journals published from January 1, 1990 (...) , to February 1, 2014, to identify risk factors for late-life breast cancer in women aged 65 years and older and to quantify the benefits and harms of screening mammography for women aged 75 years and older. FINDINGS: Age is the major risk factor for developing and dying from breast cancer. Breast cancer risk factors that reflect hormonal exposures in the distant past, such as age at first birth or age at menarche, are less predictive of late-life breast cancer than factors indicating recent hormonal

JAMA2014

39. Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines.

Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines. BACKGROUND: Controversy exists over how often and at what age mammography screening should be implemented. Given that evidence supports less frequent screening, the cost differences among advocated screening policies should be better understood. OBJECTIVE: To estimate the aggregate cost of mammography screening in the United States in 2010 and compare the costs of policy (...) recommendations by professional organizations. DESIGN: A model was developed to estimate the cost of mammography screening in 2010 and 3 screening strategies: annual (ages 40 to 84 years), biennial (ages 50 to 69 years), and U.S. Preventive Services Task Force (USPSTF) guidelines (biennial for those aged 50 to 74 years and personalized based on risk for those younger than 50 years and based on comorbid conditions for those 75 years and older). SETTING: United States. PATIENTS: Women aged 40 to 85 years

Annals of Internal Medicine2014 Full Text: Link to full Text with Trip Pro